Kawas Leen
- SEC CIK
- 0001822491
No open-market purchases or sales filed in the past year.
Current role at each company
- EIGR Eiger BioPharmaceuticals, Inc.10% Owneras of Nov 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kawas Leen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2023 (view filing)9:14 PM ET | Oct 31 | 2 days | Kawas Leen10% Owner | PPurchase | +24.3K | $0.262 | +$6.37K | +0.6%4.39M after | 2 lots |